Researchers at the Harvard Wyss Institute have developed a biomaterial-based vaccine technology that could provide prophylactic protection against bacterial infection and septic shock. The technology is delivered as a biomaterial scaffold. Once inside the body, it captures bacterial pathogens and then recruits and activates dendritic cells to initiate a broad immune response against the pathogen… Read More »
Stage two includes the over-50s, all those aged 16-49 in a flu or Covid ‘at-risk group’ and the adult household contacts of the immunosuppressed, it added. These groups “should be offered a third dose COVID-19 booster vaccine as soon as practicable after stage one, with equal emphasis on deployment of the influenza vaccine where eligible”,… Read More »
While work on COVID-19 vaccine boosters is already underway, one expert warned that emerging variants threaten to create a “window of susceptibility,” which without therapeutics could lead to more virus-inflicted death. “Of course there’s a need for boosters,” Dr. Jonathan Javitt, CEO of NRx and adjunct professor at Johns Hopkins School of Medicine, told Fox… Read More »
In a statement to WebMD, Katie Fowlie, CDC public affairs spokesperson, said: “It’s important to know that the vaccine administration process is complex and requires strong cooperation and partnership with all parties at the jurisdictional, local, and federal levels. CDC is working closely with jurisdictions to ensure as much information is submitted as possible, and… Read More »